Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Ravi K. Goyal, Gebra Cuyun Carter, Saurabh P. Nagar, Emily N. Smyth, Gregory L. Price, Yu-Jing Huang, Li Li, Keith L. Davis & James A. Kaye. (2019) Treatment patterns, survival and economic outcomes in Medicare-enrolled, older patients with HR+/HER2− metastatic breast cancer. Current Medical Research and Opinion 35:10, pages 1699-1710.
Read now
Read now
Articles from other publishers (17)
Noam Pondé, Dominique Agbor-Tarh, Lissandra Dal Lago, Larissa A. Korde, Florentine Hilbers, Christian Jackisch, Olena Werner, Richard D. Gelber, Aminah Jatoi, Amylou C. Dueck, Alvaro Moreno-Aspitia, Christos Sotiriou, Evandro de Azambuja & Martine Piccart. (2020) Tolerability and toxicity of trastuzumab or trastuzumab + lapatinib in older patients: a sub-analysis of the ALTTO trial (BIG 2-06; NCCTG (Alliance) N063D). Breast Cancer Research and Treatment 185:1, pages 107-116.
Crossref
Crossref
Long Zhang, Chaofeng Mu, Tinghong Zhang, Yingying Wang, Yili Wang, Luhui Fan, Cong Liu, Hao Chen, Jianliang Shen, Kun Wei & Huaqiong Li. (2020) Systemic Delivery of Aptamer-Conjugated XBP1 siRNA Nanoparticles for Efficient Suppression of HER2+ Breast Cancer. ACS Applied Materials & Interfaces 12:29, pages 32360-32371.
Crossref
Crossref
Marcelle Goldner, Maria A Franzoi, Lissandra D Lago & Noam Pondé. (2020) Anti-HER2 therapy for breast cancer in older patients. Future Oncology 16:19, pages 1393-1407.
Crossref
Crossref
Noam Pondé, Hans Wildiers, Ahmad Awada, Evandro de Azambuja, Coralie Deliens & Lissandra Dal Lago. (2020) Targeted therapy for breast cancer in older patients. Journal of Geriatric Oncology 11:3, pages 380-388.
Crossref
Crossref
Philip D. Poorvu, Ines Vaz-Luis, Rachel A. Freedman, Nancy U. Lin, William T. Barry, Eric P. Winer & Michael J. Hassett. (2018) Variation in guideline-concordant care for elderly patients with metastatic breast cancer in the United States. Breast Cancer Research and Treatment 168:3, pages 727-737.
Crossref
Crossref
Catherine Terret & Chiara Russo. (2018) Pharmacotherapeutic Management of Breast Cancer in Elderly Patients: The Promise of Novel Agents. Drugs & Aging 35:2, pages 93-115.
Crossref
Crossref
Hamid Jalalzadeh, Sytse C. van Beek, Reza Indrakusuma, Willem A. Bemelman, Olivier R. Busch & Ron Balm. (2017) Lasagna plots to visualize results in surgical studies. International Journal of Surgery 43, pages 119-125.
Crossref
Crossref
Jin Hyun ParkIn Sil ChoiKi Hwan KimJin-Soo KimKyung-Hun LeeTae-Yong KimSeock-Ah ImSe Hyun KimYu Jung KimJee Hyun Kim. (2017) Treatment Patterns and Outcomes in Elderly Patients with Metastatic Breast Cancer: A Multicenter Retrospective Study. Journal of Breast Cancer 20:4, pages 368.
Crossref
Crossref
Christine Leopold, Anita K. Wagner, Fang Zhang, Christine Y. Lu, Craig Earle, Larissa Nekhlyudov, Dennis-Ross Degnan & J. Frank Wharam. (2016) Racial disparities in all-cause mortality among younger commercially insured women with incident metastatic breast cancer. Breast Cancer Research and Treatment 158:2, pages 333-340.
Crossref
Crossref
Mark D. Danese, Carolina M. Reyes, Michelle L. Gleeson, Marc Halperin, Sandra L. Skettino & Joseph Mikhael. (2016) Estimating the Population Benefits and Costs of Rituximab Therapy in the United States from 1998 to 2013 Using Real-World Data. Medical Care 54:4, pages 343-349.
Crossref
Crossref
Mark D. Danese, Anthony Masaquel, Eduardo Santos, Melissa Brammer, Abraham Lee & Deepa Lalla. (2015) Estimated Life-Years Saved in Women with HER2-Positive Metastatic Breast Cancer Receiving First-Line Trastuzumab and Pertuzumab in the United States. Value in Health 18:6, pages 876-883.
Crossref
Crossref
Ines Vaz-Luis, Nancy U. Lin, Nancy L. Keating, William T. Barry, Huichuan Lii, Eric P. Winer & Rachel A. Freedman. (2015) Racial differences in outcomes for patients with metastatic breast cancer by disease subtype. Breast Cancer Research and Treatment 151:3, pages 697-707.
Crossref
Crossref
N.A. de Glas, M. Kiderlen, A.J.M. de Craen, M.E. Hamaker, J.E.A. Portielje, C.J.H. van de Velde, G.J. Liefers & E. Bastiaannet. (2015) Assessing treatment effects in older breast cancer patients: Systematic review of observational research methods. Cancer Treatment Reviews 41:3, pages 254-261.
Crossref
Crossref
Kathleen Lang, Yanni Hao, Huan Huang, Iris Lin, Jaqueline Willemann Rogerio & Joseph Menzin. (2014) Treatment patterns among elderly patients with stage IV breast cancer treated with HER-2-targeted therapy. Journal of Comparative Effectiveness Research 3:5, pages 481-490.
Crossref
Crossref
Kyung Ah YohJee Hyun Kim. (2014) Systemic Treatment of Older Patients with Advanced Breast Cancer. Korean Journal of Medicine 87:5, pages 542.
Crossref
Crossref
Rachel A. Freedman & Hyman B. Muss. (2014) Managing metastatic human epidermal growth factor receptor 2 (HER2)-positive breast cancer in the older patient. Journal of Geriatric Oncology 5:1, pages 2-7.
Crossref
Crossref
Peter A. Kaufman, Adam M. Brufsky, Musa Mayer, Hope S. Rugo, Debu Tripathy, Marianne Ulcickas Yood, Shibao Feng, Lisa I. Wang, Cheng S. Quah & Denise A. Yardley. (2012) Treatment patterns and clinical outcomes in elderly patients with HER2-positive metastatic breast cancer from the registHER observational study. Breast Cancer Research and Treatment 135:3, pages 875-883.
Crossref
Crossref